Literature DB >> 11090497

Treating dyslipidaemia in primary care. The gap between policy and reality is large in the UK.

D Monkman.   

Abstract

Mesh：

Year:  2000        PMID： 11090497      PMCID： PMC1119049          DOI： 10.1136/bmj.321.7272.1299

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey.

Authors:  P Primatesta; N R Poulter
Journal:  BMJ       Date:  2000-11-25

2.  EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.

Authors: 
Journal:  Eur Heart J       Date:  1997-10       Impact factor: 29.983

Review 3.  Might treatment of hypercholesterolaemia increase non-cardiac mortality?

Authors:  M F Oliver
Journal:  Lancet       Date:  1991-06-22       Impact factor: 79.321

4.  Secondary prevention in coronary heart disease: baseline survey of provision in general practice.

Authors:  N C Campbell; J Thain; H G Deans; L D Ritchie; J M Rawles
Journal:  BMJ       Date:  1998-05-09

5.  An assessment of the efficacy of atorvastatin in achieving LDL cholesterol target levels in patients with coronary heart disease: a general practice study.

Authors:  H A Neil; G Fowler; H Patel; Z Eminton; S Maton
Journal:  Int J Clin Pract       Date:  1999-09       Impact factor: 2.503

6.  Persistence of use of lipid-lowering medications: a cross-national study.

Authors:  J Avorn; J Monette; A Lacour; R L Bohn; M Monane; H Mogun; J LeLorier
Journal:  JAMA       Date:  1998-05-13       Impact factor: 56.272

7.  The inverse care law.

Authors:  J T Hart
Journal:  Lancet       Date:  1971-02-27       Impact factor: 79.321

8.  A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).

Authors:  T J Bowker; T C Clayton; J Ingham; N R McLennan; H L Hobson; S D Pyke; B Schofield; D A Wood
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

9.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245
View more
  7 in total

Review 1.  Basic concepts in medical informatics.

Authors:  J C Wyatt; J L Y Liu
Journal:  J Epidemiol Community Health       Date:  2002-11       Impact factor: 3.710

2.  Barriers to detecting and treating hypercholesterolaemia in patients with ischaemic heart disease: primary care perceptions.

Authors:  James Hickling; Stephen Rogers; Irwin Nazareth
Journal:  Br J Gen Pract       Date:  2005-07       Impact factor: 5.386

3.  A laboratory based intervention to improve appropriateness of lipid tests and audit cholesterol lowering in primary care.

Authors:  W S Smellie; R Lowrie; E Wilkinson
Journal:  BMJ       Date:  2001-11-24

Review 4.  Developing guidance for budget impact analysis.

Authors:  P Trueman; M Drummond; J Hutton
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

5.  High prevalence and undertreatment of hypercholesterolaemia in participants in a public stroke prevention programme in austria.

Authors:  Bernhard Iglseder; Titus Moroder; Wolfgang Staffen; Gunther Ladurner
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

6.  Low prevalence of lipid lowering drug use in older men with established coronary heart disease.

Authors:  P H Whincup; J R Emberson; L Lennon; M Walker; O Papacosta; A Thomson
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

7.  Decision tools in health care: focus on the problem, not the solution.

Authors:  Joseph Liu; Jeremy C Wyatt; Douglas G Altman
Journal:  BMC Med Inform Decis Mak       Date:  2006-01-20       Impact factor: 2.796
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.